- Home
- CRGX vs OPOF Comparison
CRGX vs OPOF Comparison
Compare CRGX & OPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- OPOF
- Stock Information
- Founded
- CRGX 2021
- OPOF 1922
- Country
- CRGX United States
- OPOF United States
- Employees
- CRGX N/A
- OPOF N/A
- Industry
- CRGX
- OPOF Major Banks
- Sector
- CRGX
- OPOF Finance
- Exchange
- CRGX Nasdaq
- OPOF Nasdaq
- Market Cap
- CRGX 190.0M
- OPOF 200.6M
- IPO Year
- CRGX 2023
- OPOF N/A
- Fundamental
- Price
- CRGX $4.27
- OPOF $39.63
- Analyst Decision
- CRGX Hold
- OPOF
- Analyst Count
- CRGX 7
- OPOF 0
- Target Price
- CRGX $4.67
- OPOF N/A
- AVG Volume (30 Days)
- CRGX 647.1K
- OPOF 15.0K
- Earning Date
- CRGX 08-11-2025
- OPOF 07-24-2025
- Dividend Yield
- CRGX N/A
- OPOF 1.39%
- EPS Growth
- CRGX N/A
- OPOF 55.28
- EPS
- CRGX N/A
- OPOF 1.96
- Revenue
- CRGX N/A
- OPOF $61,370,000.00
- Revenue This Year
- CRGX $58.18
- OPOF N/A
- Revenue Next Year
- CRGX N/A
- OPOF N/A
- P/E Ratio
- CRGX N/A
- OPOF $20.52
- Revenue Growth
- CRGX N/A
- OPOF 5.28
- 52 Week Low
- CRGX $3.00
- OPOF $13.70
- 52 Week High
- CRGX $25.45
- OPOF $40.88
- Technical
- Relative Strength Index (RSI)
- CRGX 45.02
- OPOF 61.55
- Support Level
- CRGX $4.33
- OPOF $38.51
- Resistance Level
- CRGX $4.48
- OPOF $40.32
- Average True Range (ATR)
- CRGX 0.19
- OPOF 0.74
- MACD
- CRGX -0.02
- OPOF -0.06
- Stochastic Oscillator
- CRGX 21.14
- OPOF 93.37
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.